Table 4.
Kruskal–Wallis H test statistics for the antitumor effect of CFZ in B16-F1 tumor-bearing mice.
Days | N | Chi-Square (χ2) | Degree of Freedom (df) | Significance (p) |
---|---|---|---|---|
0 | 20 | 3.909 | 3 | 0.271 |
1 | 20 | 6.020 | 3 | 0.111 |
2 | 20 | 13.118 | 3 | 0.004 ** |
3 | 20 | 13.674 | 3 | 0.003 ** |
4 | 20 | 14.842 | 3 | 0.002 ** |
5 | 20 | 12.389 | 3 | 0.006 ** |
6 | 20 | 16.419 | 3 | 0.001 ** |
7 | 20 | 15.642 | 3 | 0.001 ** |
8 | 20 | 15.915 | 3 | 0.001 ** |
9 | 20 | 17.010 | 3 | 0.001 ** |
N: the sum of sample sizes for all samples. ** p < 0.01.